| tacrolimus intravenous / Generic mfg. |
2012-001909-24: Pharmacokinetics of tacrolimus in the first days after heart and lung transplantation Farmacokinetiek van tacrolimus in de eerste dagen na hart en long transplantatie |
|
|
| Ongoing | 4 | 30 | Europe | tacrolimus, RVG222236 and RVG18107, Capsule, hard, Prograft®, tacrolimus | University Medical Center Utrecht, University Medical Center Utrecht | Heart and lung transplantation, first days after transplantation Hart en long transplantatie, eerste dagen na transplantatie, Heart and lung transplantation, first days after transplantation Hart en long transplantatie, eerste dagen na transplantatie, Body processes [G] - Physical Phenomena [G01] | | | | |
2015-005559-29: Fluctuations in tacrolimus levels in renal transplant patients treated with different tacrolimus formulations. |
|
|
| Ongoing | 4 | 120 | Europe | Prograft, Advagraf, Envarsus, Capsule, Tablet, Prograft, Advagraf, Envarsus | Erasmus MC, Chiesi | kidney transplantation, kidney transplantation, Body processes [G] - Immune system processes [G12] | | | | |
2017-000718-52: A pilot study to prevent post- renal trasplant diabetes in patients at risk Estudio piloto para prevenir la diabetes porst-transplante en pacientes de riesgo |
|
|
| Ongoing | 4 | 50 | Europe | ENVARSUS, prograf, Tablet, ENVARSUS, Prograf | Hospital Universitario de Canarias, Chiesi Farmaceutici S.p.A. | diabetes post-renal trasnplant diabetes post-trasplante renal, diabetes afer a renal trasnplant diabetes tras transplante renal, Body processes [G] - Metabolic Phenomena [G03] | | | | |
NCT03511560: Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation |
|
|
| Active, not recruiting | 4 | 50 | US | Tacrolimus Extended Release Oral Tablet, Envarsus XR, Tacrolimus, Prograf | Columbia University, Veloxis Pharmaceuticals | Renal Transplant Rejection, Kidney Transplant Failure and Rejection | 07/20 | 07/21 | | |
2019-004946-13: Conversion to extended-release MeltDose® tacrolimus after kidney transplantation - impact on glucose metabolism and lipid profile |
|
|
| Not yet recruiting | 4 | 50 | Europe | Prograf, Prolonged-release tablet, Envarsus, prograf | Univeristy Hospital Tuebingen, Chiesi GmBh | stable adult kidney transplant, stable adult kidney transplant, Body processes [G] - Metabolic Phenomena [G03] | | | | |
| Active, not recruiting | 4 | 100 | Europe | Rituximab, Mabthera, Tacrolimus, Advagraf, Adoport, Prograf, Mycophenylate mofetil, MMF, Cellcept, Hydrocortisone, Prednisolone | Guy's and St Thomas' NHS Foundation Trust, Astellas Pharma Europe Ltd. | Function of Renal Transplant | 10/20 | 10/22 | | |
|
NCT03216447: A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant |
|
|
| Recruiting | 4 | 150 | RoW | Advagraf, Prograf | Chang Gung Memorial Hospital, Astellas Pharma Taiwan, Inc. | Liver Transplantation | 08/23 | 09/25 | | |
PTAAK, NCT03841097: Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants |
|
|
| Recruiting | 4 | 60 | US | Extended Release Tacrolimus Tablets, LCPT, Envarsus XR®, Immediate Release Tacrolimus Capsule, IR-TAC, Prograf® | Roy D. Bloom, MD, Veloxis Pharmaceuticals | Kidney Transplant; Complications | 03/25 | 09/25 | | |
OPERATOR, NCT04838288: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™ |
|
|
| Recruiting | 4 | 60 | US | Change from Prograf to Envarsus XR, Change from Tacrolimus to Envarsus XR | Vanderbilt University Medical Center, Veloxis Pharmaceuticals | Renal Transplant | 06/24 | 06/24 | | |
